ES2843374T3 - Aparato para usar en una terapia de la enfermedad hepática - Google Patents

Aparato para usar en una terapia de la enfermedad hepática Download PDF

Info

Publication number
ES2843374T3
ES2843374T3 ES07824370T ES07824370T ES2843374T3 ES 2843374 T3 ES2843374 T3 ES 2843374T3 ES 07824370 T ES07824370 T ES 07824370T ES 07824370 T ES07824370 T ES 07824370T ES 2843374 T3 ES2843374 T3 ES 2843374T3
Authority
ES
Spain
Prior art keywords
albumin
blood
individual
endotoxin
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07824370T
Other languages
English (en)
Spanish (es)
Inventor
Nathan Davies
Rajiv Jalan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yaqrit Ltd
Original Assignee
Yaqrit Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yaqrit Ltd filed Critical Yaqrit Ltd
Application granted granted Critical
Publication of ES2843374T3 publication Critical patent/ES2843374T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3496Plasmapheresis; Leucopheresis; Lymphopheresis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES07824370T 2006-10-27 2007-10-29 Aparato para usar en una terapia de la enfermedad hepática Active ES2843374T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0621452.2A GB0621452D0 (en) 2006-10-27 2006-10-27 Therapy for liver disease
PCT/GB2007/004126 WO2008050148A2 (en) 2006-10-27 2007-10-29 Therapy for liver disease

Publications (1)

Publication Number Publication Date
ES2843374T3 true ES2843374T3 (es) 2021-07-16

Family

ID=37546125

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07824370T Active ES2843374T3 (es) 2006-10-27 2007-10-29 Aparato para usar en una terapia de la enfermedad hepática

Country Status (8)

Country Link
US (1) US8480607B2 (enExample)
EP (1) EP2061533B1 (enExample)
JP (1) JP5276002B2 (enExample)
CN (1) CN101541357B (enExample)
DK (1) DK2061533T3 (enExample)
ES (1) ES2843374T3 (enExample)
GB (1) GB0621452D0 (enExample)
WO (1) WO2008050148A2 (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009216769A1 (en) * 2008-02-20 2009-08-27 Novartis Ag Heterocyclic inhibitors of stearoyl-CoA desaturase
WO2013028809A2 (en) 2011-08-22 2013-02-28 Medtronic, Inc. Dual flow sorbent cartridge
US10624924B2 (en) 2012-03-12 2020-04-21 Grifols, S.A. Method and device for treating blood cholesterol disorders
US11154648B2 (en) 2013-01-09 2021-10-26 Medtronic, Inc. Fluid circuits for sorbent cartridge with sensors
US9713666B2 (en) 2013-01-09 2017-07-25 Medtronic, Inc. Recirculating dialysate fluid circuit for blood measurement
US9144640B2 (en) 2013-02-02 2015-09-29 Medtronic, Inc. Sorbent cartridge configurations for improved dialysate regeneration
US9943780B2 (en) 2013-11-26 2018-04-17 Medtronic, Inc. Module for in-line recharging of sorbent materials with optional bypass
US9884145B2 (en) 2013-11-26 2018-02-06 Medtronic, Inc. Parallel modules for in-line recharging of sorbents using alternate duty cycles
US10537875B2 (en) 2013-11-26 2020-01-21 Medtronic, Inc. Precision recharging of sorbent materials using patient and session data
US9895477B2 (en) 2013-11-26 2018-02-20 Medtronic, Inc. Detachable module for recharging sorbent materials with optional bypass
US10052612B2 (en) 2013-11-26 2018-08-21 Medtronic, Inc. Zirconium phosphate recharging method and apparatus
US10004839B2 (en) 2013-11-26 2018-06-26 Medtronic, Inc. Multi-use sorbent cartridge
RU2539139C1 (ru) * 2014-02-13 2015-01-10 Артем Сергеевич Арапов Способ лечения отека мозга у больных хроническими заболеваниями печени
AU2015201496B2 (en) 2014-06-03 2019-10-31 Grifols Worldwide Operations Limited Use of plasmapheresis to treat blood pressure disorders
US20170092985A1 (en) * 2014-06-05 2017-03-30 Sony Corporation Secondary battery-use electrolytic solution, secondary battery, battery pack, electric vehicle, electric power storage system, electric power tool, and electronic apparatus
EP3160531B1 (en) 2014-06-24 2019-08-14 Medtronic Inc. Replenisihing urease in dialysis systems using a urease introducer
EP3160532B1 (en) 2014-06-24 2019-09-18 Medtronic Inc. A urease introduction system for replenishing urease in a sorbent cartridge
US10286380B2 (en) 2014-06-24 2019-05-14 Medtronic, Inc. Sorbent pouch
US10357757B2 (en) 2014-06-24 2019-07-23 Medtronic, Inc. Stacked sorbent assembly
EP3160529B1 (en) 2014-06-24 2019-11-13 Medtronic Inc. Replenishing urease in dialysis systems using urease pouches
WO2015199766A1 (en) 2014-06-24 2015-12-30 Medtronic, Inc. Modular dialysate regeneration assembly
WO2016145211A1 (en) 2015-03-10 2016-09-15 Life Warmer Inc. Thermic infusion system
US10981148B2 (en) 2016-11-29 2021-04-20 Medtronic, Inc. Zirconium oxide module conditioning
US11167070B2 (en) 2017-01-30 2021-11-09 Medtronic, Inc. Ganged modular recharging system
US10960381B2 (en) 2017-06-15 2021-03-30 Medtronic, Inc. Zirconium phosphate disinfection recharging and conditioning
US11707580B2 (en) 2017-09-08 2023-07-25 Life Warmer Inc. Thermic infusion system dry tube detector
US12285552B2 (en) 2018-08-14 2025-04-29 Mozarc Medical Us Llc Precision dialysis therapy based on sorbent effluent analysis
US11213616B2 (en) 2018-08-24 2022-01-04 Medtronic, Inc. Recharge solution for zirconium phosphate
WO2020120801A1 (en) * 2018-12-14 2020-06-18 Bia Separations D.O.O. A method for depletion or removal of endotoxin from an endotoxin-containing source or potentially endotoxin-containing source
WO2020216437A1 (en) * 2019-04-23 2020-10-29 Espire Technologies Gmbh Device and method for localising or identifying malignancies
EP3786642A1 (en) * 2019-08-30 2021-03-03 ESPIRE Technologies GmbH Method for functional characteristics of proteins for classification of patients to be associated to a specific disease
GB202004775D0 (en) * 2020-03-31 2020-05-13 Ucl Business Ltd Apparatus
US12397093B2 (en) 2021-05-18 2025-08-26 Mozarc Medical Us Llc Sorbent cartridge designs
GB202307837D0 (en) 2023-05-25 2023-07-12 Yaqrit Ltd Dialysis method
WO2024254494A2 (en) * 2023-06-09 2024-12-12 Kanzo Biomedicines, Inc. Liver support systems and methods of use

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4093612A (en) * 1975-08-04 1978-06-06 Research Corporation Selective removal of albumin from blood fluids and compositions therefore
JPS5670028A (en) 1979-11-12 1981-06-11 Teijin Ltd Polymer bonding with albumin
US4476715A (en) * 1983-03-11 1984-10-16 Murphy Jack L Mud metering tank monitoring system
JPH0738880B2 (ja) 1983-06-24 1995-05-01 東レ株式会社 エンドトキシン血症治療剤
US5179018A (en) 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US5594113A (en) * 1988-06-23 1997-01-14 Associates Of Cape Cod, Inc. Endotoxin binding and neutralizing protein and uses thereof
US5476715A (en) * 1989-10-03 1995-12-19 Fresenius Ag Particulate adsorbent for the removal of biomacromolecules such as LDL and endotoxins from whole blood in extracorporeal circuits
DE4309410A1 (de) * 1993-03-19 1995-02-16 Stange Jan Material, Verfahren und Einrichtung zur selektiven Trennung frei gelöster und stoffgebundener Stoffe aus flüssigen Stoffgemischen sowie Verfahren zur Herstellung des Materials
JP3413985B2 (ja) 1994-09-29 2003-06-09 東レ株式会社 選択分離膜およびそれを用いた血液処理装置
DE4435612A1 (de) * 1994-10-05 1996-04-11 Braun Melsungen Ag Verfahren zur simultanen Entfernung von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus einer wäßrigen Flüssigkeit
IT1279209B1 (it) 1995-05-16 1997-12-04 Bellco Spa Filtro dializzatore/reattore atto ad effettuare la cattura di endotossine, e procedimento per la sua realizzazione.
JPH1071201A (ja) * 1996-01-19 1998-03-17 Terumo Corp 血液浄化排液再生装置、血液浄化液回路および血液浄化装置
JPH11137672A (ja) * 1997-11-05 1999-05-25 Asa Sangyo Kk 腹膜透析液回収・再生方法及び装置
JPH11225725A (ja) * 1998-02-16 1999-08-24 Yoshinori Naito 冷凍食品および冷凍食品の製造方法
EP1063289A1 (en) 1998-03-03 2000-12-27 JMS Co., Ltd. Liver cell clones for artifical liver and extracorporeal liver assist device
JPH11225752A (ja) 1998-02-16 1999-08-24 Jms Co Ltd 人工肝臓用肝細胞クローンおよび体外循環肝補助装置
JP2000107286A (ja) * 1998-10-07 2000-04-18 Akira Sakai 腹膜透析液の灌流装置及び灌流法
US8026096B1 (en) * 1998-10-08 2011-09-27 Protein Sciences Corporation In vivo active erythropoietin produced in insect cells
US6774102B1 (en) * 1999-09-29 2004-08-10 Gambro Dialysatoren Gmbh & Co. Kg Extracorporeal endotoxin removal method
US6365147B1 (en) * 1999-10-13 2002-04-02 New Jersey Institute Of Technology Methods for removing endotoxins from biological solutions using immobilized metal affinity chromatography
US6787040B2 (en) * 2000-05-16 2004-09-07 Immunocept, L.L.C. Method and system for colloid exchange therapy
JP2003135594A (ja) * 2001-10-30 2003-05-13 Toray Medical Co Ltd 体液浄化カラム
SE522692C2 (sv) * 2002-03-27 2004-03-02 Gambro Lundia Ab Förfarande och anordning för avlägsnande av delvis proteinbundna substanser
JP4201313B2 (ja) 2002-04-11 2008-12-24 旭化成クラレメディカル株式会社 有害物質結合アルブミン除去システム
JP2003310752A (ja) 2002-04-25 2003-11-05 Toray Ind Inc 生理活性物質固定化成型品の製造方法
SE526038C2 (sv) 2002-07-08 2005-06-21 Gambro Lundia Ab Polymeraffinitetsmatris, förfarande för framställning därav och anvädning därav
JP2004121445A (ja) * 2002-10-01 2004-04-22 Akira Sakai 酸化ストレス消去材、それを有する透析液循環回路及び酸化ストレス消去法
CA2514981A1 (en) * 2003-03-12 2004-09-23 Fresenius Kabi Deutschland Gmbh Use of recombinant albumin in dialysis after liver failure
WO2004082737A2 (en) * 2003-03-17 2004-09-30 Hemavation Llc Extracorporeal blood treatment device for removing blood toxins, and methods thereof
JP4352775B2 (ja) * 2003-06-19 2009-10-28 株式会社ジェイ・エム・エス 血液透析濾過装置
US20050037331A1 (en) * 2003-08-13 2005-02-17 William Galbraith Apparatuses and methods for reducing albumin in samples
CN2810611Y (zh) * 2005-06-22 2006-08-30 浙江科锐生物科技有限公司 一种体外人工肝支持系统
US20080031874A1 (en) * 2006-02-06 2008-02-07 Sanders Martin E Treatment of endotoxemia using endotoxin neutralizing agents

Also Published As

Publication number Publication date
GB0621452D0 (en) 2006-12-06
EP2061533B1 (en) 2020-11-25
CN101541357A (zh) 2009-09-23
JP2010507432A (ja) 2010-03-11
CN101541357B (zh) 2012-07-04
US20100025328A1 (en) 2010-02-04
WO2008050148A3 (en) 2008-07-17
EP2061533A2 (en) 2009-05-27
WO2008050148A2 (en) 2008-05-02
US8480607B2 (en) 2013-07-09
DK2061533T3 (da) 2020-12-21
JP5276002B2 (ja) 2013-08-28

Similar Documents

Publication Publication Date Title
ES2843374T3 (es) Aparato para usar en una terapia de la enfermedad hepática
Hsiao et al. The decline of autophagy contributes to proximal tubular dysfunction during sepsis
Davis et al. Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I
Abe et al. The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis
Arnaud et al. Tumor lysis syndrome and AKI: beyond crystal mechanisms
JP6055464B2 (ja) 循環血中の可溶性ウロキナーゼ受容体の低減
Han et al. Secretory-defect distal renal tubular acidosis is associated with transporter defect in H+-ATPase and anion exchanger-1
Honda et al. De novo membranous nephropathy and antibody‐mediated rejection in transplanted kidney
Debiec et al. Antenatal membranous glomerulonephritis with vascular injury induced by anti-neutral endopeptidase antibodies: toward new concepts in the pathogenesis of glomerular diseases
JP2011107130A (ja) インドキシル硫酸の産生の阻害剤のスクリーニング方法、インドキシル硫酸代謝産生阻害剤、及び腎障害軽減剤
Kimura et al. Lenalidomide as a beneficial treatment option for renal impairment caused by light chain deposition disease
EP4126106A1 (en) Apparatus for extracorporeal removal of albumin and endotoxin from blood
WO2022161484A1 (en) Methods of treating chronic active antibody-mediated rejection using btk inhibitors
WO2014120642A1 (en) Diagnosis and treatment of hepatorenal syndrome
WO2024241060A1 (en) Dialysis method
US20100297018A1 (en) Prognosis and therapy of liver failure
Cardoso Fernandes et al. New Onset Nephrotic-Range Proteinuria in a Patient with Chronic Kidney Disease-Not Always What it Seems
Wang et al. Experience with ABO-incompatible kidney transplantation
Gollasch Insights in Nephrology: 2021
Trajceska et al. SP099 COMPLICATIONS AND RISKS OF PERCUTANEOUS RENAL BIOPSY
Cardoso et al. Not the usual suspect
Lönnbro Widgren Membranous Nephropathy-Challenges in diagnostics and treatment
Bhanji et al. 211 LIVER TRANSPLANTATION FOR OVERLAP SYNDROMES OF AUTOIMMUNE LIVER DISEASES
Sato et al. Kidney-limited recurrence in a patient with microscopic polyarteritis
Gerber CD13 Regulation of Albuminuria in Response to Renal Injury